Neurology

Article	Citations
Intravenous Immune Globulins vs Plasma Exchange Usage in Patients with Neuromuscular and Neuro-immunological Conditions (P4-13.007)	317
Increased Healthcare Cost and Mental Health Burden among Patients with Essential Tremor: A Retrospective Observational Study in A Large US Commercially Insured and Medicare Advantage Population (P15-1	310
Postpartum Risk of Cerebral Venous Thrombosis (P10-10.006)	195
Towards Machine Learning-Based Cognitive Examination (S2.010)	191
Reduced Time to Treatment After Implementation of a Standardized Guideline for the Diagnostic Evaluation and Acute Management of Suspected Autoimmune Encephalitis in Hospitalized Adult Patients (P9-8.	188
Teaching NeuroImage: Foramen Magnum Dural Arteriovenous Fistula Presenting With Thoracolumbar Myelopathy	179
Spinal Cord Infarction Associated with Patent Formale Ovale and Venous Thromboembolism: A Case Report (P8-13.005)	149
Standardized Inpatient Telestroke to Improve Access to Stroke Specialists (P12-14.015)	139
Frailty increases the risk of Alzheimer’s disease in non-demented individuals: a longitudinal cohort study (P6-3.008)	134
Improving Median Overall Survival (OS) of Glioblastoma (GBM) Patients by Optimizing Standard of Care (SOC) Through Multidisciplinary Team Work and Combination Therapies Including Tumor Treating Fields	134
Role of the UNC13 Family in Human Diseases: A Literature Review (P9-2.003)	128
Predicting Cognitive Decline Using Baseline Data in Cognitively Unimpaired Older Adults: Results from the A4 Trial (P2-3.018)	121
Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species (P8-3.007)	120
Traumatic Brain Injury and Depressive Symptoms in Community Dwelling Older Adults (P3-4.007)	107
Lifestyle Contributors to Frequent Headaches in Youth	106
Exploring Clinical Outcomes of ABCDEF Bundle Implementation in Neurocritical Patients: Insights from Two Years of ICU Humanization (P9-7.006)	104
Analysis of the Efficacy of Efgartigimod in a Refractory OMG Patient (P1-11.019)	103
Frequency and Severity of Neurological Symptoms Following Gluten Exposure in Individuals with Celiac Disease (P1-2.010)	101
Association Between COVID-19 Vaccination and Rhabdomyolysis in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.006)	100
Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005)	100
A Clinical Decision Rule Predicting Outcomes of Emergency Department Patients with Altered Mental Status (P5-12.003)	99
Association Between COVID-19 Vaccination and Cerebrovascular Accidents in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.002)	97
Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC) (P18-12.005)	97
A Clinical Bulbar Assessment Scale for ALS/MND: Preliminary Validation (S11.007)	96
Cenobamate Plasma Concentrations in Patients Reaching ≥50% or 100% Responder Rates for ≥12 Months: A Post-hoc Analysis (S13.004)	95

Teaching Video NeuroImage: Pattern-Induced Seizures Without Photosensitivity in Glutaric Aciduria	87
Peripheral Neuropathy	87
Development and Validation of a Nomogram Prediction Model for New Stroke in Community Population (P10-13.004)	87
Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio? (S7.010)	86
Perspectives From Members of an Online Community on Their Communications With Health Care Professionals About Migraine Treatment: A Social Listening Analysis (P17-2.003)	86
Amyloid beta deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort (P1-1.Virtual)	86
Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage (P12-10.008)	84
Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Protocol for an observational study. (S29.007)	83
Pathogenic Th17 Cells in Autoimmune Myasthenia Gravis Exhibit a Pro-inflammatory Transcriptomic Signature that Promotes Disease Pathogenesis (S41.008)	83
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy (S5.006)	81
Quantitative Cerebrovascular Reactivity Atlas In Children (P14-5.003)	81
Completing the NIHSS Score Prior to CT Scan to Reduce Time to Acute Intervention for Stroke: A Quality Improvement Project (P17-10.008)	81
Long-term Treatment with Galcanezumab in 29 Patients with Chronic Migraine: Results from the 3-year Continued Access Program of the REGAIN Study (P1-1.Virtual)	80
Resting-state Regional Cerebral Blood Flow Alterations in Macrovasculature and Microvasculature in Parkinson’s Disease: A Systematic Review and Meta-analysis (P3-5.013)	79
Rethinking Thunderclap Headaches: A Critical Look at Cerebral Venous Sinus Thrombosis (P3-13.020)	78
Exploring Racial Disparities in Advanced Care Planning Documentation for Stroke Patients (P10-13.020)	78
Automated Data Extraction Using Large Language Models in Vascular and Interventional Neurology Research: Towards an AI Fully Assistant Automated Research (P9-14.007)	77
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry (P7-6.008)	77
Brain Perfusion Imaging and Cardiac Thrombus Detection	75
Demographic and Regional Trends of Meningitis-related Mortality in the United States from 1999 to 2020: a CDC WONDER Analysis (P3-10.004)	74
Capturing Patient and Caregiver Perspectives on Parkinson’s Disease in Zambia: A Methodology (P6-11.014)	73
IgG4-Related Hypertrophic Pachymeningitis Mimicking Neuromyelitis Optica: a Case Report (P10-8.004)	73
Modifiable Vascular Risk Factors and Subsequent Brain Metrics in Hispanic/Latino Populations	72
Clinical and Genetic Profiles of Congenital Myasthenic Syndromes: A Single Tertiary Care Center Experience from Saudi Arabia (P12-11.029)	71
Elevated Pre-hospital Blood Pressure is Associated with Reduced Infarct Volume in Large Vessel Occlusion Ischemic Strokes (P12-13.016)	71
Patient Education and Unmet Needs: Pregnancy and Postpartum Counseling in MS (P6-1.014)	71
Teaching Video NeuroImage: Reflex Epilepsy—Seizures Triggered by a Geometric Pattern	70
Evaluating Brain Health in Women	70
Clinical evidence that treatment with pepinemab, a novel regulator of neuroinflammation, provides cognitive benefit to patients with Huntington’s and potentially other neurodegenerative diseases (P3-1	69
Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic (P18-10.009)	69
Distinguishing Quantitative EEG Correlates of Psychogenic Non-Epileptic Seizures versus Epilepsy (P1-1.Virtual)	69
Residual Symptoms and Long-term Outcomes after All-Cause Autoimmune Encephalitis (P5-1.002)	68
Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation (S27.008)	67
Study Design of AOC 1001-CS1, a Phase 1/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myoton	67
Diagnosis of Stroke and Prognosis of Interventions Using Imaging and Machine Learning (P1-1.Virtual)	67
Sustainability of Seizure Control With Adjunctive Cenobamate in the Phase 3 C021 Study (P12-8.001)	67
Real-World Experience of Perampanel Monotherapy in Epilepsy Patients with Focal-Onset and Generalized-Onset Seizures (P15-8.002)	66
Open-ended, value-based decision making requires semantic memory: a computational, imaging, and clinical study (P1-6.005)	66
The Association of Posterior Reversible Encephalopathy Syndrome with COVID-19: A Systematic Review (P1-1.Virtual)	66
Serving Los Angeles County Patients with Teleneurology, A Clinical Tool Here to Stay (P18-8.007)	65
BRAT1 Associated Leukodystrophy exacerbated by Lymphoma directed Chemotherapy (P13-9.005)	65
Ponesimod Shows Improved Effect on Brain Volume Compared with Other DMTs, A Model Based Meta-Analysis (P1-1.Virtual)	65
Novel Ischemic Stroke Treatment Protocol for Salvageable Penumbra in Acute Small Vessel Disease (S6.010)	64
Temporal Mapping of Trigeminal Neuralgia Lesions to Symptom Onset in Multiple Sclerosis: When Do the Lesions Occur and What Do They Tell Us? (P16-4.001)	63
Prevalence of Comorbidities in a National Sample of Lewy Body Dementia Caregivers (P15-3.005)	63
Cardiac MRI in Duchenne and Becker Muscular Dystrophy (P14-13.001)	63
Artificial intelligence identifies spectral biomarkers for use in adaptive deep brain stimulation in Parkinson’s disease (S16.004)	62
A Novel IONM Protocol for Distal Femoral Extension Osteotomies (P6-6.010)	62
Delayed Toxic Encephalopathy Masquerading as Creutzfeldt-Jakob disease (P2-9.007)	62
Comparison of Pharmacokinetic Profiles and Safety Outcomes with Peginterferon Beta-1a Administration in Black/African American and White Participants (P4-4.009)	62

Improved Access to Rapid Electroencephalography at a Community Hospital Reduces Inter-Hospital Transfers for Suspected Non-Convulsive Seizures (P6-8.003)	62
Wobbling Through the Spectrum: Anti-GQ1b Antibody Syndrome Presenting with Generalized Myoclonus and Ataxia (P4-8.018)	61
Case Report of a Unique Structural Cause for Rapidly Progressive Orthostatic Syncope (P7-2.001)	61
Outcomes of a Three Week Interdisciplinary Intensive Outpatient Treatment Program for Mild-Moderate Traumatic Brain Injury in Veterans and First Responders (P7-4.006)	60
Overdiagnosis of Autism Spectrum Disorder: Diagnostic and Management Challenges in a Pediatric Outpatient Clinic (P6-6.003)	60
Hereditary Transthyretin Amyloidosis at Geisinger Medical Center: A Four-year Multidisciplinary Clinic Experience (P6-11.033)	59
Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM (S2.008)	59
Having Second Thoughts About Parkinson Diagnosis	59
NETSseq Identifies Novel Therapeutic Targets for Neurodegenerative Diseases (P3-3.008)	58
Consent Deviations in an Acute Ischemic Stroke Clinical Trial (P5-13.017)	58
Effect Sizes of Once-daily Valbenazine for Chorea Associated with Huntington’s Disease: A Post-hoc Analysis of KINECT®-HD Data (P10-5.012)	58
Quantitation of Hypocretin Neuropeptides (Orexin-A and -B) in Human Cerebrospinal Fluid via HPLC with MS/MS Detection (P1-4.002)	58
Localizing Lesions in the Peripheral Nervous System using Generative Artificial Intelligence (P1-2.009)	57
Spontaneous Closure Of A Dural Arteriovenous Fistula: A Case Report (P5-14.011)	57
Pediatric SMART Syndrome in a 10-year-old boy: A Case-Report (P5-6.005)	57
The Midbrain Paradox: Bilateral Vertical Gaze Palsy from a Single Sided Lesion (P2-11.007)	57
Severity of Hearing Loss as a Predictor of Dementia Risk: Insights from the ARIC Study (P9-3.013)	57
Radiological Signs in Spinal Cord Infarct (SCI) and Association with Anatomic Location. (P9-13.005)	56
Multimodal Regression Based Assessment of Longitudinal Evolution Trends in Inflammatory Myositis (IIM) (P3-11.018)	55
Inter-Institutional Collaborative Opportunity For Medical Students in the Neurosciences: Annual Student Interest Group in Neurology (SIGN) Forum (P5-5.021)	55
Teaching Neuro Images : CNS actinomycosis in an immunocompetent patient	55
Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis	54
Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)	54
My First Patient With Alzheimer's	54
Reader Response: Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	54
Comparative Efficacy of Adjuvant Rifampicin, Levofloxacin, and Their Combination in Tuberculous Meningitis With and Without HIV Co-infection: A Systematic Review and Meta-Analysis	54
NMDA Receptor Encephalitis With Severe Orofacial Dyskinesias Treated With Tramadol and Clonazepam	53
Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma with Neurologic Involvement	53
Coexistance of Probable Neurosarcoidosis and Generalized Myasthenia Gravis: Case Report	53
Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study	53
Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis	53
Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Disease Activity in Multiple Sclerosis Patients	53
Opinion & Special Articles: The Core Identity of the Neurologist	52
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy	52
Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents	52
Author Response: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis	52
Reframing Conceptions of Surgical Candidacy	52
Contributions of Purine Synthesis and Recycling During Brain Development: Relevance to Lesch Nyhan Disease (S39.009)	51
Leucine Zipper 4 Autoantibody–Associated Myeloneuropathy With Multiple Cranial Neuropathies and Longitudinally Extensive Tractopathy	51
Child Neurology: Creatine Biosynthesis Disorder in an Adolescent With Capgras Syndrome and Reduplicative Paramnesia	51
Classifying Papilledema Using Machine Learning – Modernizing Frisén Grading (S12.001)	51
Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS	50
Cancer Risk in Patients With Muscular Dystrophy and Myotonic Dystrophy	50
Clinical Reasoning: A 56-Year-Old Woman With Right-Sided Weakness and Recurrent MRI Lesions	50
Blood Pressure Variability and Cognition in Black and White Older Adults Over 18 Years of Follow-up	50
Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal Degeneration	50
Cluster-Based White Matter Signatures and the Risk of Dementia, Stroke, and Mortality in Community-Dwelling Adults	50
Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial	50
Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage	50
Early Identification of Candidates for Epilepsy Surgery	50
Editors' Note: Sex-Dependent Effects of Cardiometabolic Health and APOE4 on Brain Age: A Longitudinal Cohort Study	50
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis	49
The Frequency of Optic Disc Hemorrhages and Other Retinal Findings on Fundoscopic Examination in Acute MOGAD Optic Neuritis (P11-8.005)	49
MOG Antibody-Associated Disease Manifesting as MRI-Negative Encephalitis: A Case Report and Literature Review (P16-1.004)	49
Reader Response: Days at Home After Traumatic Brain Injury: Moving Beyond Mortality to Evaluate Patient-Centered Outcomes Using Population Health Data	49
Efficacy and Safety of Targeted Immunotherapy with ANX005 in Treating Guillain-Barré Syndrome: A Phase 3 Multicenter Study (PL5.006)	49
Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy	48
Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics	48
Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients (P7-5.008)	48
Performance Assessment of the New EUROLINE Neurologic Syndrome 15 Ag (IgG) for the Determination of Autoantibodies Associated with Neurological Disorders	48
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy–Associated Myopathies	48
Group D Salmonella Meningitis in the Neonate (P5-6.010)	47
Author Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study	47
Autoimmune Cerebellar Ataxia Associated with TNF-Alpha Blocking Therapy in a Patient with Rheumatoid Arthritis: A Case Report and Literature Review (P8-8.003)	47
Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes	47
Nitrous Oxide-Induced Vitamin B12 Deficiency and Myelopathy: A Report of Two Cases (P11-2.006)	47
Jugular Variant Bow-Hunter’s Syndrome from Sternocleidomastoid Entrapment of the Internal Jugular Vein (P11-10.001)	47
Variants in PNPLA8 are Associated with Developmental Epileptic Encephalopathy and Cerebellar Atrophy. (P6-5.002)	46
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)	46
A Case of Contrast-Induced Encephalopathy in The Setting of Acute Stroke Thrombolysis (P1-1.Virtual)	46
Accurate Test of Limb Isometric Strength (ATLIS) as an Outcome Measure in ALS and as a Marker of Upper Motor Neuron Involvement in Primary Lateral Sclerosis (S11.010)	46
An IDH Wildtype, EGFR Amplified and TERT Promoter Mutated Astrocytoma that is Clinically and Molecularly Incompatible with the Diagnosis of Glioblastoma, IDH Wildtype. (P13-9.001)	46
A Rare Case of Giant Cell Arteritis Presenting With Transient Polycranial Neuropathies (P6-12.004)	46
Functional Parcellation of the Cingulate Gyrus in Epilepsy Surgical Planning: Electrical stimulation, Electrocorticography, and fMRI study (P4-8.005)	46
Lest We Forget: Ammonia in Encephalopathic Cancer Patients (P1-1.Virtual)	45
Proteomic profiling of sporadic late-onset nemaline myopathy (P15-13.001)	45
Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier after Stroke (S33.001)	45
Risk and Predictors of Relapse after Smoking Cessation in Patients with Ischemic Stroke and Transient Ischemic Attack (P1-1.Virtual)	45
Assessing Social Cognition Across Dementia Subtypes (P6-6.004)	44
Neuroradiological profile of Rhinoorbitocerebral mucormycosis in COVID-19 pandemic. (S18.007)	44

Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010)	43
Experiences with a virtual nationwide seminar series for neuroimmunology trainees (P14-6.001)	43
Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (P1-7.001)	43
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	43
Acute Anterograde Amnesia with Bilateral Hippocampal and Globus Pallidus Lesions (P4-12.007)	43
In-Hospital Glucose Measurements are Associated with Mortality after Thrombectomy for Acute Ischemic Stroke (P4-10.005)	43
Impact of Multiple Sclerosis Disease-Modifying Therapies on Effectiveness of SARS-Cov-2 Vaccines: A Longitudinal Total Population Study of National Health Service (NHS) England (S5.008)	43
Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)	43
Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease (P7-11.012)	42
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation in Neurodegeneration via Modification of Extracellular Vesicles (S36.006)	42
Iron accumulation correlates with disease severity in patients with Multiple System Atrophy (P15-11.002)	42
Neurocognitive Manifestations of Individuals with NF1 Microdeletions (P14-9.007)	42
The Bulbar Imposter: A Case Presentation of Foix-Chavany-Marie Syndrome (P10-10.001)	42
Analysis of the Epidemiologic Profile, Prevalence, and Incidence of Migraine out of 15,490 Spontaneous Intracranial Hypotension Patients from a Multicenter Record Database (TriNetX) (P2-12.008)	42
Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series (P2-2.006)	42
Determinants of Disparate Disability Accumulation in Black, Hispanic, and White Patients With Multiple Sclerosis (P1-1.Virtual)	42
Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS (S17.004)	41
Machine-learning Assisted Swallowing Assessment: A Deep Learning-based Quality Improvement Tool to Screen for Post-stroke Dysphagia (S6.004)	41
Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review (P11-2.001)	41
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes (P13-5.020)	41
African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients (P9-3.010)	41
Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment (P7-5.014)	41
Patient Sera from the First Week Postpartum after Preeclampsia Increase Human Blood Brain Barrier Permeability (S25.003)	40
Levamisole-associated Toxic Multifocal Inflammatory Leukoencephalopathy: A Case Report (P7-3.006)	40
Identification of a Novel NOTCH3 Mutation in a Case of CADASIL Initially Diagnosed as Demyelinating Disease (P3-3.010)	40
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment (P6-12.011)	40
Gadolinium Enhancement Patterns in Leptomeningeal Disease (P2-2.001)	40
Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component (P13-13.004)	40
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)	40
Evaluating Quality of Website-Derived Concussion Information (P8-1.005)	40
Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition. (P4-4.007)	39
Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka (P3-10.002)	39
A Gender Affirming Experience; The RNS System Tracking Seizure Frequency During Gender Changing Hormonal Therapy (P5-9.006)	39
Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006)	39
Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy	39
Development of eIF2B Activator ABBV-CLS-7262 as a Novel Treatment for Vanishing White Matter Disease (P2-8.001)	39
COVID-19 Disrupts Sleep Architecture by Reducing N3 Stage Sleep (S25.010)	39
Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review (P5-11.014)	38
What’s that Mass? A Sphenoid Lesion Causing Cavernous Sinus Syndrome (P3-14.009)	38
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)	38
Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017)	38
‘Code Brain’- Mannequin Based Simulation Exercise to Enhance Identification, Evaluation, and Management of Cerebral Herniation for Neurology Residents. (P5-5.027)	38
Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life (P14-8.005)	38
Designing Transgene Vectors for ALS Therapeutics (P11-4.010)	38
4 mA tDCS improves walking ability in PSP: A case study (P9-11.012)	38
Computational Models of Age-associated Cognitive Slowing and Memory Loss (P6-9.010)	38
Reconsidering the Ethics of Provocation Techniques for Psychogenic Non-epileptic Seizures and Proposed Ethical Guidelines for Use (P2-10.005)	38
A Ten-year Delayed Diagnosis of Hereditary Spastic Paraplegia Type-10: Key Clinical, Electrodiagnostic, and Genetic Findings (P11-11.004)	37
A pioneer in the History of Women in Neurology - Historical Review of the Life and Contributions of Augusta Déjerine-Klumpke (P4-11.009)	37
Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review (P2-3.011)	37
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia	37
Role of 18F-Florzolotau PET in Diagnostic and Therapeutic Decision-Making for Cognitive Impairment (N4.001)	37
Neuroimaging Evidence of Cortical-subcortical Network Involvement in Patients with Cortical Lateralized Periodic Discharges (P5-1.004)	37
Endovascular Therapy for NIHSS ≤5	37
Multimodal Approach to NMOSD Relapse Treatment: Experience with Two Cases (P10-8.011)	37
Serum Neuroinflammatory Biomarkers and Long-term Cognitive Dysfunction (P11-13.002)	37
Personalized Alzheimer’s Risk Reduction Software Improves Calculated Alzheimer’s Risk: A Digital, Decentralized, Randomized Controlled Trial (P1-3.004)	36
7T MRI Leptomeningeal Enhancement and Brain Atrophy Are Associated with Alterations in Arginine-polyamine Metabolism in Multiple Sclerosis (P11-6.007)	36
Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection (P4-10.007)	36
The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004) (P4-14.017)	36
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms (P10	36
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixa	36
The Path to Finding a Unifying Diagnosis – A Case Report of Mitchell Syndrome in a Pediatric Patient (P2-8.005)	36
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables (P1-5.022)	36
Drug-Resistant GAD65-Associated Epilepsy: Pre-Surgical Evaluation and Comparison to Temporal Lobe Epilepsy of Other Etiology (P2-9.005)	36
Impact of an Inpatient Stroke Education Program on Stroke Knowledge in Lusaka, Zambia (S24.005)	35
A Fatal Case of CNS Actinomyces Mimicking Tolosa-Hunt Syndrome: Is it Time to Reevaluate Diagnostic Criteria? (P10-10.004)	35
Cognitive sequelae in MOG antibody-associated disease (P13-5.025)	35
Pregnancy-related Anticipatory Guidance for People with Epilepsy in Pediatric and Adult Neurology (P1-9.015)	35
Socioeconomic Disparities in Aspiration Pneumonia Hospitalizations in Parkinson’s Disease Patients (P2-5.006)	35
Prospective Long-term Seizure Outcomes in Medically-resistant Focal Epilepsy Subjects with Neuromodulation Devices (P3-1.009)	35
Physiological β-Amyloid Clearance by the Liver and Its Therapeutic Potential for Alzheimer’s Disease (P12-3.010)	35
Perceived Stress and its Association with Sleep Quality in Patients with Neuropathic Pain and Distal Symmetric Polyneuropathy (P3-11.020)	35
Unveiling the Diagnostic and Therapeutic Challenges: A Singular Case of Syphilitic Myelitis in an HIV-Positive Patient (P5-10.007)	35
Racial Disparities in Mental Health Among Stroke Survivors in the REDUCE Study (P1-13.014)	35
Teaching NeuroImage: Wallerian Degeneration of the Corticospinal Tract After Cerebral Hemorrhage	35
Blood Pressure Variability as a Marker of Sympathetic Hyperreactivity in Postpartum Patients with Preeclampsia, with and without Chronic Hypertension (P2-7.003)	35
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)	35
Collateral Score and Clot Burden Score in the Era of Tenecteplase (P3-13.007)	34
Expanding the Clinical Spectrum of NUBPL Associated Disorders: Previously Unidentified NUBPL Variants Uncovered by Genome Sequencing in Sibling Pair (P10-6.009)	34
Contributions of Traumatic Brain Injury and Repetitive Head Impacts to Chronic Deficits in Recognition Memory in Military Veterans (P2-3.020)	34
Correlation of Headache Frequency and Intensity with the Risk of Obstructive Sleep Apnea in Patients with Idiopathic Intracranial Hypertension (P10-12.007)	34
Effgartigimod Helps Avert Post-Thymectomy Crises in Patients with Myasthenia Gravis Classified as MGFA IIIb or Higher (P7-11.026)	34
Benign Paroxysmal Positional Vertigo: The “SemontPLUS Maneuver” is more effective than the Epley Maneuver – a Prospective Tri-national Randomized Single-Blinded Trial in 195 Patients (S12.003)	34
Deep Brain Stimulation (DBS) in Pediatric Dystonia: The Youngest Case of Neuromodulation for Refractory Acquired Dystonia and Status Dystonicus with 1-year Follow-up (P10-5.008)	34
Detecting Smouldering Multiple Sclerosis with Real-world Mobility Monitoring (P2-1.001)	34
The Grand Masquerade of a Rare Neurological Illness: A Case Report of Anti-IgLON5 Antibody Disease (P3-8.008)	34
Brain White Matter Microstructural Alterations in Behcet’s Syndrome Correlate with Cognitive Impairment and Disease Severity: A Diffusion Tensor Imaging Study (P3-1.002)	34
Cortical Microglial Activation on [F-18]PBR06-PET Predicts Progression Independent of Relapse Activity (PIRA) in Multiple Sclerosis: A 4.5-year Longitudinal Study (S33.006)	34
PRAX-562 is a Well-Tolerated, Novel Persistent Sodium Channel Blocker with Broad Anticonvulsant Activity in Multiple DEE Mouse Models (S34.007)	34
Amelogenesis Imperfecta and Epilepsy	34
Neurocognitive Function and Psychiatric Comorbidities in Patients with Epilepsy with Eyelid Myoclonia (P7-9.002)	34
Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) with Direct Cystic Infiltration of the Optic Chiasm and Tracts (P1-9.003)	34
Measuring Synaptic Density and Dopamine Transporter Availability in Parkinson's Disease: A PET Imaging Study with 11C-UCB-J and 18F-FE-PE2I (P7-3.007)	33
Editors' Note: Patient Travel Distance to Neurologist Visits	33